BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 14, 2026
Breaking News: BioWorld Science 2025 Year in Review
See today's BioWorld Science
Home
» ATL-201, a di-siRNA, reduces seizures in KCNT1-driven epilepsy
To read the full story,
subscribe
or
sign in
.
Neurology/psychiatric
ATL-201, a di-siRNA, reduces seizures in KCNT1-driven epilepsy
Dec. 12, 2024
Pathogenic variants in the
KCNT1
gene, which encodes potassium channel subfamily T member 1, cause a severe childhood developmental epileptic encephalopathy.
BioWorld Science
Conferences
Neurology/psychiatric